Thursday, 09 February 2006 00:00

Clinical Trials Update: Feb. 9, 2006

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Breast Cancer

This study will evaluate whether zoledronic acid continues to decrease skeletal-related events (like breaking bones) after 9-12 doses during 10 to 12 months. To participate, you must be female, 18 or older, and have a diagnosis of breast cancer that has spread to the bone. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat29.html.

-----

Uterine Cancer

This research study will evaluate whether treatment with BAY 43-9006 can slow or stop the growth of uterine cancer that has recurred after initial treatment or has become metastatic (spread to another part of the body). Research site located in Duarte, Calif.

More Information

Please see http://www.centerwatch.com/patient/studies/cat519.html.

-----

Shingles

If you experience shingles pain after shingles have dissipated, you may be eligible to participate in this clinical study of an investigational medication. To qualify, you must be between 18 and 90 inclusive, be in good health, and have at least six months of pain since shingles have healed. Research site located in San Antonio, Texas.

More Information

Please see http://www.centerwatch.com/patient/studies/cat225.html.

-----

Copyright 2006 CenterWatch. All rights reserved.